NGC Update Service: December 23, 2013

National Guideline Clearinghouse (NGC)

December 23, 2013

New This Week

Guideline Summaries

American Association of Clinical Endocrinologists

American Association of Neuroscience Nurses

Program in Evidence-based Care

University of Texas at Austin School of Nursing, Family Nurse Practitioner Program

Withdrawn Summaries

These summaries have been withdrawn from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that they are no longer current. See the Guideline Archive for a complete list of all guidelines that have been withdrawn from the NGC Web site.

Please refer to NGC's FAQ page if you have additional questions about guidelines recently withdrawn.

Infectious Diseases Society of America

  • The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America.
  • Treatment of Aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Kaiser Permanente Care Management Institute

  • Colorectal cancer screening clinical practice guideline.
  • Coronary artery disease (CAD) clinical practice guidelines.
  • Osteoporosis/fracture prevention clinical practice guidelines.

National Collaborating Centre for Cancer

  • Prostate cancer. Diagnosis and treatment.

National Collaborating Centre for Primary Care

  • Lipid modification. Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.

Announcements

How to Participate

  • Submit guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
  • Suggest a guideline for possible inclusion: Submit your suggestions for evidence-based guidelines that you would like to see included in NGC.
  • Suggest a Guideline Synthesis topic: We welcome your suggestions for guideline synthesis topics!

Revised Inclusion Criteria

NGC has revised its Inclusion Criteria! Visit our updated Inclusion Criteria page to see the new criteria and send us your comments.

Conference News

  • The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, is available on the G-I-N Web site.

U.S. Food and Drug Administration (FDA) Advisory

  • December 17, 2013: Methylphenidate ADHD Medications: FDA is warning that methylphenidate products, one type of stimulant drug used to treat attention deficit hyperactivity disorder (ADHD), may in rare instances cause prolonged and sometimes painful erections known as priapism. Based on a recent review of methylphenidate products, FDA updated drug labels and patient Medication Guides to include information about the rare but serious risk of priapism. If not treated right away, priapism can lead to permanent damage to the penis.

NGC's Sister Resources